300146 汤臣倍健
已收盘 03-24 15:00:00
资讯
新帖
简况
汤臣倍健：研发费用下降主要系委外研发未达预期收到供应商退款
证券之星 · 03-23 18:33
汤臣倍健：研发费用下降主要系委外研发未达预期收到供应商退款
股市必读：汤臣倍健年报 - 第四季度单季净利润同比增长42.00%
证券之星 · 03-23 02:28
股市必读：汤臣倍健年报 - 第四季度单季净利润同比增长42.00%
汤臣倍健：目前已在东南亚主要国家进行布局
新京报 · 03-22 12:27
汤臣倍健：目前已在东南亚主要国家进行布局
汤臣倍健(300146)2月28日股东户数6.46万户，较上期减少4.08%
证券之星 · 03-21
汤臣倍健(300146)2月28日股东户数6.46万户，较上期减少4.08%
汤臣倍健(300146.SZ)发布2025年度业绩，归母净利润7.82亿元，增长19.81%
智通财经 · 03-20
汤臣倍健(300146.SZ)发布2025年度业绩，归母净利润7.82亿元，增长19.81%
汤臣倍健：坚持以消费者需求为导向
证券之星 · 03-18
汤臣倍健：坚持以消费者需求为导向
股市必读：汤臣倍健（300146）3月13日董秘有最新回复
证券之星 · 03-16
股市必读：汤臣倍健（300146）3月13日董秘有最新回复
汤臣倍健：公司将综合考虑对投资者的持续回报及公司经营发展的资金需求等确定利润分配预案
证券之星 · 03-11
汤臣倍健：公司将综合考虑对投资者的持续回报及公司经营发展的资金需求等确定利润分配预案
汤臣倍健：公司新品开发将以消费者健康需求为导向
证券之星 · 03-09
汤臣倍健：公司新品开发将以消费者健康需求为导向
股市必读：汤臣倍健（300146）3月6日董秘有最新回复
证券之星 · 03-09
股市必读：汤臣倍健（300146）3月6日董秘有最新回复
汤臣倍健：致力于做大做强主业，实现可持续、有质量发展
证券之星 · 03-05
汤臣倍健：致力于做大做强主业，实现可持续、有质量发展
股市必读：汤臣倍健（300146）3月2日董秘有最新回复
证券之星 · 03-03
股市必读：汤臣倍健（300146）3月2日董秘有最新回复
汤臣倍健：旗下拥有保健功能为“有助于抗氧化”“有助于改善皮肤水分状况”的产品
中金财经 · 03-02
汤臣倍健：旗下拥有保健功能为“有助于抗氧化”“有助于改善皮肤水分状况”的产品
汤臣倍健：行业相关法规的陆续完善将为合规企业的健康持续发展创造较好的条件
证券之星 · 02-28
汤臣倍健：行业相关法规的陆续完善将为合规企业的健康持续发展创造较好的条件
汤臣倍健：公司已递交轻络素相关的新功能申报及产品注册申请
证券之星 · 02-28
汤臣倍健：公司已递交轻络素相关的新功能申报及产品注册申请
汤臣倍健新提交“未公开”等2件商标注册申请
证券之星 · 02-15
汤臣倍健新提交“未公开”等2件商标注册申请
汤臣倍健：以消费者健康需求为核心
证券之星 · 02-11
汤臣倍健：以消费者健康需求为核心
汤臣倍健：公司坚持实施积极、持续、稳定的分红政策
证券之星 · 02-10
汤臣倍健：公司坚持实施积极、持续、稳定的分红政策
汤臣倍健：公司产品均按照国家批准的保健功能进行合规标识与宣传
证券之星 · 02-06
汤臣倍健：公司产品均按照国家批准的保健功能进行合规标识与宣传
汤臣倍健：公司将持续加强客服人员产品培训与考核
证券之星 · 01-26
汤臣倍健：公司将持续加强客服人员产品培训与考核
加载更多
公司概况
公司名称：
汤臣倍健股份有限公司
所属行业：
食品制造业
上市日期：
2010-12-15
主营业务：
汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司已获得145项原料及配方等发明专利。
发行价格：
110.00
{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":10.86,"timestamp":1774335792000,"preClose":10.76,"halted":0,"volume":17341956,"delay":0,"changeRate":0.0093,"floatShares":1121000000,"shares":1692000000,"eps":0.5388,"marketStatus":"已收盘","change":0.1,"latestTime":"03-24 15:00:00","open":10.84,"high":10.86,"low":10.64,"amount":187000000,"amplitude":0.0204,"askPrice":10.86,"askSize":493,"bidPrice":10.85,"bidSize":552,"shortable":0,"etf":0,"ttmEps":0.5388,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"adjPreClose":10.76,"symbolType":"stock","openAndCloseTimeList":[[1774315800000,1774323000000],[1774328400000,1774335600000]],"highLimit":11.84,"lowLimit":9.68,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1691677031,"isCdr":false,"pbRate":1.64,"roa":"--","peRate":20.155902,"roe":"7.18%","epsLYR":0.47,"committee":0.074067,"marketValue":18372000000,"turnoverRate":0.0155,"status":0,"floatMarketCap":12171000000},"requestUrl":"/m/hq/s/300146","defaultTab":"news","newsList":[{"id":"2621722507","title":"汤臣倍健：研发费用下降主要系委外研发未达预期收到供应商退款","url":"https://stock-news.laohu8.com/highlight/detail?id=2621722507","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621722507?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:33","pubTimestamp":1774261994,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健03月23日在投资者关系平台上答复投资者关心的问题。公司坚定实施“科学营养”战略，持续打造科技核心竞争力优势，推动科研成果转化，研发费用下降主要系委外研发未达预期收到供应商退款，同时公司优化研发资源配置，提升研发资源投入效率所致，不影响公司科研创新能力及战略实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300031486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","BK0107","BK0114","BK0226","300146","BK0042"],"gpt_icon":0},{"id":"2621745124","title":"股市必读：汤臣倍健年报 - 第四季度单季净利润同比增长42.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621745124","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621745124?lang=zh_cn&edition=full","pubTime":"2026-03-23 02:28","pubTimestamp":1774204090,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告汤臣倍健2025年实现主营收入62.65亿元，同比下降8.38%；归母净利润7.82亿元，同比增长19.81%；扣非净利润6.86亿元，同比增长9.49%。全年经营活动现金流净额12.14亿元，同比增长76.94%。中信证券股份有限公司关于汤臣倍健股份有限公司2025年度募集资金存放与使用情况的专项核查报告截至2025年12月31日，募集资金净额30.91亿元，累计投入12.54亿元，期末余额20.74亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300000814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146"],"gpt_icon":0},{"id":"2621171324","title":"汤臣倍健：目前已在东南亚主要国家进行布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2621171324","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621171324?lang=zh_cn&edition=full","pubTime":"2026-03-22 12:27","pubTimestamp":1774153620,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 3月22日，汤臣倍健在业绩电话会表示，公司将以本土化需求为核心驱动国际业务扩张，目前已在东南亚主要国家进行布局，将加速扩大东南亚线下渠道覆盖，推动线上渠道实现增长突破。\n公司还表示，2026年，公司将推动传统电商、兴趣电商、跨境及商超等业务全线恢复并实现快速增长。线上渠道将作为主力增长渠道，将通过重点突破兴趣电商与跨境业务，确保传统电商持续增长驱动；线下药店渠道目标保持稳定，商超渠道则作为重点发力方向之一，将通过创新差异化产品和精细化运营实现突破。","market":"sh","thumbnail":"https://media.bjnews.com.cn/cover/2026/03/22/5699743814558754181.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/03/22/5699743814558754181.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1774149094129760.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1774149094129760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0107","BK0146","BK0114","BK0028","BK0226","300146","BK0042"],"gpt_icon":0},{"id":"2621764028","title":"汤臣倍健(300146)2月28日股东户数6.46万户，较上期减少4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621764028","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621764028?lang=zh_cn&edition=full","pubTime":"2026-03-21 17:03","pubTimestamp":1774083811,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汤臣倍健披露，截至2026年2月28日公司股东户数为6.46万户，较12月31日减少2749.0户，减幅为4.08%。在食品加工行业个股中，汤臣倍健股东户数高于行业平均水平，截至2月28日，食品加工行业平均股东户数为3.32万户。从股价来看，2025年12月31日至2026年2月28日，汤臣倍健区间涨幅为0.42%，在此期间股东户数减少2749.0户，减幅为4.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032100011936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0028","BK0042","BK0146","300146","BK0226","BK0114"],"gpt_icon":0},{"id":"2620739748","title":"汤臣倍健(300146.SZ)发布2025年度业绩，归母净利润7.82亿元，增长19.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620739748","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620739748?lang=zh_cn&edition=full","pubTime":"2026-03-20 21:19","pubTimestamp":1774012760,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汤臣倍健 发布2025年年度报告，该公司营业收入为62.65亿元，同比减少8.38%。归属于上市公司股东的净利润为7.82亿元，同比增长19.81%。基本每股收益为0.47元。此外，拟向全体股东每10股派发现金红利4.5元(含税)。报告期，主品牌“汤臣倍健”实现收入33.49亿元，同比下降10.38%;“健力多”实现收入7.27亿元，同比下降10.00%;“lifespace”国内产品实现收入2.14亿元，同比下降32.01%，境外LSG实现收入9.34亿元，同比上升16.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"汤臣倍健(300146.SZ)发布2025年度业绩，归母净利润7.82亿元，增长19.81%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300146"],"gpt_icon":0},{"id":"2620236839","title":"汤臣倍健：坚持以消费者需求为导向","url":"https://stock-news.laohu8.com/highlight/detail?id=2620236839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620236839?lang=zh_cn&edition=full","pubTime":"2026-03-18 16:51","pubTimestamp":1773823873,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：官媒报道，现在的国人营养过剩，满大街挺着大肚子的胖子很多，许多人都在希望减肥、少吃。请问，未来，公司在传统膳食营养产品这一块有什么变化？汤臣倍健回复：投资者您好！公司坚持以消费者需求为导向，围绕主要核心品类并结合渠道特性进行产品研发创新，为消费者提供更加多样化的产品选择。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800028262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0146","BK0042","BK0107","BK0028","BK0226","300146"],"gpt_icon":0},{"id":"2619648839","title":"股市必读：汤臣倍健（300146）3月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2619648839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619648839?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:50","pubTimestamp":1773600620,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，汤臣倍健报收于11.62元，下跌0.09%，换手率0.81%，成交量9.08万手，成交额1.06亿元。董秘最新回复投资者： 建议公司扩大核心品类研发投入 创造产品持续竞争力来扩大转化效率 牺牲短期利润来维护长期竞争力董秘： 感谢您的建议。交易信息汇总资金流向3月13日主力资金净流出369.79万元；游资资金净流入588.88万元；散户资金净流出219.09万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0028","BK0042","BK0146","300146","BK0226","BK0114"],"gpt_icon":0},{"id":"2618594050","title":"汤臣倍健：公司将综合考虑对投资者的持续回报及公司经营发展的资金需求等确定利润分配预案","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618594050?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:03","pubTimestamp":1773234188,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：公司今年业绩比去年优秀，2025年度分红应该也要大于去年，请转告大股东、董事会。谢谢汤臣倍健回复：投资者您好！公司将综合考虑对投资者的持续回报及公司经营发展的资金需求等确定利润分配预案，具体请以公司公开披露信息为准。感谢您的建议。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100037899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0114","BK0226","BK0146","BK0107","300146"],"gpt_icon":0},{"id":"2618235206","title":"汤臣倍健：公司新品开发将以消费者健康需求为导向","url":"https://stock-news.laohu8.com/highlight/detail?id=2618235206","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618235206?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:36","pubTimestamp":1773056163,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健03月09日在投资者关系平台上答复投资者关心的问题。老龄化程度的持续加深为膳食营养补充剂行业发展带来增长机会，公司新品开发将以消费者健康需求为导向，加速科研创新成果向产品端转化落地，为消费者提供更加多样化和优质的产品选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900029622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0146","BK0028","BK0107","BK0042","BK0226","300146"],"gpt_icon":0},{"id":"2618469556","title":"股市必读：汤臣倍健（300146）3月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618469556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618469556?lang=zh_cn&edition=full","pubTime":"2026-03-09 01:40","pubTimestamp":1772991623,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，汤臣倍健报收于11.52元，上涨1.5%，换手率1.02%，成交量11.44万手，成交额1.31亿元。董秘最新回复投资者： 你好董秘，麻烦问一下今年公司会有多少新品发布和上市？应该增加这方面的销售渠道引导董秘： 感谢您的建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900000746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0042","BK0146","BK0107","300146","BK0114","BK0028"],"gpt_icon":0},{"id":"2617542703","title":"汤臣倍健：致力于做大做强主业，实现可持续、有质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2617542703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617542703?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:52","pubTimestamp":1772715172,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健03月05日在投资者关系平台上答复投资者关心的问题。公司持续关注市值表现，致力于做大做强主业，实现可持续、有质量发展，长期创造价值回报广大投资者。公司坚持在整体战略规划下审慎决策投资并购事项，具体情况需以公司公开披露信息为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500037423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0226","BK0146","300146","BK0028","BK0114","BK0107"],"gpt_icon":0},{"id":"2616352405","title":"股市必读：汤臣倍健（300146）3月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616352405","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616352405?lang=zh_cn&edition=full","pubTime":"2026-03-03 01:17","pubTimestamp":1772471828,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，汤臣倍健报收于11.82元，下跌1.99%，换手率2.01%，成交量22.52万手，成交额2.67亿元。董秘最新回复投资者： 请问公司是否有美白类护肤类的产品。公司主营膳食营养补充剂业务，旗下拥有保健功能为“有助于抗氧化”“有助于改善皮肤水分状况”的产品。国家市场监督管理总局目前尚未将“美白”单独列为可声称的保健功能。交易信息汇总资金流向3月2日主力资金净流出2440.01万元；游资资金净流入2284.63万元；散户资金净流入155.38万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300000702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0107","BK0028","300146","BK0114","BK0226","BK0042"],"gpt_icon":0},{"id":"2616387557","title":"汤臣倍健：旗下拥有保健功能为“有助于抗氧化”“有助于改善皮肤水分状况”的产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2616387557","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616387557?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:24","pubTimestamp":1772443459,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司是否有美白类护肤类的产品。有无进军化口福妆品领域的计划？汤臣倍健回复：投资者您好！公司主营膳食营养补充剂业务，旗下拥有保健功能为“有助于抗氧化”“有助于改善皮肤水分状况”的产品。国家市场监督管理总局目前尚未将“美白”单独列为可声称的保健功能。感谢关注。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260302/32037934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0226","BK0114","300146","BK0028","BK0107","BK0042","BK0146"],"gpt_icon":0},{"id":"2614814816","title":"汤臣倍健：行业相关法规的陆续完善将为合规企业的健康持续发展创造较好的条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2614814816","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614814816?lang=zh_cn&edition=full","pubTime":"2026-02-28 17:51","pubTimestamp":1772272271,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)02月28日在投资者关系平台上答复投资者关心的问题。投资者提问：2026年3月份开始，保健食品线上推广销售将迎来更严厉监管，公司主要收入为线下销售，是否意味着公司终于迎来大展身手的时候？建议公司积极开展相关工作，推进公司业绩增长，为公司和投资者创造更美好的未来！汤臣倍健回复：投资者您好！行业相关法规的陆续完善将为合规企业的健康持续发展创造较好的条件。感谢您的建议。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022800011767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0107","BK0146","BK0114","BK0042","BK0226","300146"],"gpt_icon":0},{"id":"2614981687","title":"汤臣倍健：公司已递交轻络素相关的新功能申报及产品注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2614981687","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614981687?lang=zh_cn&edition=full","pubTime":"2026-02-28 17:51","pubTimestamp":1772272270,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)02月28日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的产品轻络素和pcc1目前进展到哪一步了，有没有持续跟踪？汤臣倍健回复：投资者您好！公司已递交轻络素相关的新功能申报及产品注册申请，目前尚在审批中；相关产品进展请以公司官方发布的信息为准。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022800011766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0107","BK0114","BK0042","BK0028","BK0226","300146"],"gpt_icon":0},{"id":"2611490291","title":"汤臣倍健新提交“未公开”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2611490291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611490291?lang=zh_cn&edition=full","pubTime":"2026-02-15 06:09","pubTimestamp":1771106965,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日汤臣倍健股份有限公司新提交“未公开”等2件商标注册申请。商标申请详情如下：今年以来汤臣倍健股份有限公司新申请注册商标11件，截止目前公司共持有注册商标7918件，另有412件商标尚在注册申请中。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目56次；财产线索方面有商标信息5687条，专利信息711条，著作权信息57条；此外企业还拥有行政许可864个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300146","BK0226","BK0146","BK0042","BK0028","BK0107"],"gpt_icon":0},{"id":"2610493316","title":"汤臣倍健：以消费者健康需求为核心","url":"https://stock-news.laohu8.com/highlight/detail?id=2610493316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610493316?lang=zh_cn&edition=full","pubTime":"2026-02-11 18:06","pubTimestamp":1770804365,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：近年来各种网红益生菌、保健产品在各大平台销售火爆，价格战打的火热。这种行业现状公司是如何应对的呢？汤臣倍健回复：投资者您好！公司始终以消费者健康需求为核心，通过科研创新推动产品升级与成果转化，适应渠道特性持续优化产品组合，为消费者提供多样化的产品选择；同时持续提升精细化运营能力，夯实核心竞争力，以适应行业竞争格局的长期变化。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100028927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0107","BK0146","BK0114","BK0042","BK0226","300146"],"gpt_icon":0},{"id":"2610617444","title":"汤臣倍健：公司坚持实施积极、持续、稳定的分红政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2610617444","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610617444?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:48","pubTimestamp":1770713286,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)02月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司是准备开始提升市值管理，减少分红了么？汤臣倍健回复：投资者您好！公司持续关注市值表现，始终聚焦主业，致力于实现可持续、有质量发展，长期创造价值回报广大投资者。公司坚持实施积极、持续、稳定的分红政策，上市以来累计现金分红金额占累计归属于上市公司股东净利润的比例超过70%。2025年度分红计划请以公司公告为准。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000026497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0226","BK0042","BK0107","300146","BK0114"],"gpt_icon":0},{"id":"2609530646","title":"汤臣倍健：公司产品均按照国家批准的保健功能进行合规标识与宣传","url":"https://stock-news.laohu8.com/highlight/detail?id=2609530646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609530646?lang=zh_cn&edition=full","pubTime":"2026-02-06 11:33","pubTimestamp":1770348797,"startTime":"0","endTime":"0","summary":"根据国家市场监督管理总局的规定，目前允许保健食品声称的保健功能共24项，其中包括“有助于抗氧化”“有助于增强免疫力”等功能，尚未将“抗衰老”或“抵抗病毒”单独列为可声称的保健功能。公司产品目前均按照国家批准的保健功能进行合规标识与宣传。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600015918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0146","BK0028","BK0114","BK0107","BK0042","300146"],"gpt_icon":0},{"id":"2606633215","title":"汤臣倍健：公司将持续加强客服人员产品培训与考核","url":"https://stock-news.laohu8.com/highlight/detail?id=2606633215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606633215?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:24","pubTimestamp":1769419450,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健01月26日在投资者关系平台上答复投资者关心的问题。雪球平台用户“汤汤讲解员”非公司官方账号。公司将持续加强客服人员产品培训与考核。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600022721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0042","BK0114","BK0028","BK0107","300146","BK0226"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774343707931,"stockEarnings":[{"period":"1week","weight":-0.0819},{"period":"1month","weight":-0.1107},{"period":"3month","weight":-0.1048},{"period":"6month","weight":-0.0796},{"period":"1year","weight":-0.0791},{"period":"ytd","weight":-0.1041}],"compareEarnings":[{"period":"1week","weight":-0.0665},{"period":"1month","weight":-0.0658},{"period":"3month","weight":-0.0272},{"period":"6month","weight":-0.0105},{"period":"1year","weight":0.1333},{"period":"ytd","weight":-0.0392}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"64574人(较上一季度减少4.08%)","perCapita":"17355股","listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","registeredCapital":"169167万元","survey":" 汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司已获得145项原料及配方等发明专利。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}